Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis
BMJ Open Feb 03, 2020
Grint1, DJ, et al. – Researchers performed a prospective observational cohort study to evaluate the safety of live attenuated varicella-zoster vaccination when administered to immunosuppressed individuals. This study included 168,767 participants age-eligible for varicella-zoster vaccination who were registered at a general practice in England contributing data to Clinical Practice Research Datalink between 2013 and 2017. Despite data supporting inadvertent vaccination of immunosuppressed individuals with live zoster vaccination, there is a dearth of evidence of severe consequences, including hospitalization. This should assuage primary care staff and encourage vaccination of mildly immunosuppressed individuals who do not meet current thresholds for contraindication.
55 lakhs+ doctors trust M3 globally
Unlimited access to original articles by experts
Secure: we never sell your data
Signing up takes less than 2 mins